Clinical Trial Update: Efficacy and Safety of VEGF Trap Eye in Diabetic Macular Edema (DME) With Central Involvement [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of VEGF Trap-Eye (aflibercept) for diabetic macular edema with central involvement; the study is completed and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• VEGF Trap-Eye (aflibercept) (aflibercept)

Snippet

Sponsor: Bayer | Conditions: Macular Edema | Phase 3 | Status: COMPLETED | Results posted: 2016-04-05